Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News SWK Holdings Corp SWKH

Alternate Symbol(s):  SWKHL

SWK Holdings Corporation is engaged in specialty finance and asset management business. The Company’s segments include Finance Receivables and Pharmaceutical Development. Finance Receivables segment is a healthcare capital provider, which offers customized financing solutions to a range of life science companies, institutions, and inventors. This segment is primarily focused on monetizing cash... see more

Recent & Breaking News (NDAQ:SWKH)

Enteris BioPharma Completes Expansion of Manufacturing Facility and Announces Launch of CDMO Business Segment

PR Newswire May 3, 2021

SWK Holdings Confirms Receipt of Non-Binding Proposal from Carlson Capital L.P.

PR Newswire April 6, 2021

SWK Holdings Corporation Announces Financial Results for Fourth Quarter and Full-Year 2020

PR Newswire March 31, 2021

Acerus Announces Amendment to Credit Agreement

GlobeNewswire March 26, 2021

Sincerus Pharmaceuticals Completes Financing With SWK To Support The Demand For Its Customized Dermatologic Medicines

PR Newswire March 24, 2021

Enteris BioPharma Announces Dr. Gary Shangold to Host Webinar on Utilization of 505(b)(2) Regulatory Pathway in Drug Development

PR Newswire March 16, 2021

SWK Holdings to Present at Maxim Group's Emerging Growth Virtual Conference

PR Newswire March 15, 2021

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

PR Newswire February 16, 2021

Enteris BioPharma to Host Webinar on Strategies for Initiating Phase 1 Clinical Development with Limited API

PR Newswire January 12, 2021

Enteris BioPharma Highlights 2020 Achievements and 2021 Outlook

PR Newswire January 7, 2021

Flowonix Medical, Inc. and SWK Holdings Corporation Announce Closing of $33 Million Financing

PR Newswire January 4, 2021

SWK Holdings' Subsidiary, Enteris BioPharma, Receives Second Milestone Payment from Cara Therapeutics

PR Newswire December 24, 2020

Enteris BioPharma to Participate in Biotech Showcase Digital and BIO @ JPM During "J.P. Morgan Week 2021"

PR Newswire December 17, 2020

SWK Holdings Corporation Announces Financial Results for Third Quarter 2020

PR Newswire November 13, 2020

SWK Holdings Corporation to Participate in A.G.P.'s Virtual Healthcare Symposium

PR Newswire November 11, 2020

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

PR Newswire October 29, 2020

SWK Holdings' Subsidiary, Enteris BioPharma, Receives Milestone Payment from Cara Therapeutics

PR Newswire October 27, 2020

Financial Services Virtual Investor Conference Presentations Now Available for On-Demand Viewing

Canada NewsWire September 28, 2020

OTC Markets Group Announces Agenda for Financial Services Virtual Investor Conference on September 24th

Canada NewsWire September 21, 2020

SWK Holdings to Present at Two Upcoming Investor Conferences

PR Newswire September 15, 2020